Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imatinib for Early COVID-19 in Aged Patients
NCT04357613Phase 2Unknown
- Sponsor
- Centre Hospitalier de Versailles
- Start
- Sep 2020
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of imatinib in coronavirus disease 2019 (COVID-19), sponsored by Centre Hospitalier de Versailles. Status: unknown.
02
Drugs
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04357613.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04357613.